ESR1 and ductal breast carcinoma in situ: We previously stably expressed 4-hydroxytamoxifen (4HT)-inducible Snai1, a Snai1-estrogen receptor (Snai1-ER) fusion, in MCF10DCIS.com human basal breast epithelial cancer cells (referred to as DCIS) [33].